We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

January 31, 2018

In Re: Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litigation

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 31, 2018

    Allergan, Generic Cos. Battle Over Restasis Launch Plans

    Companies hoping to sell generic versions of Allergan’s dry-eye medication Restasis have told a New York federal court overseeing multidistrict antitrust litigation that they’ll only provide information about their launch dates to the branded-drug maker’s outside counsel, but Allergan insists that its in-house attorneys can be trusted.

4 other articles on this case. View all »

Parties

To view the parties, register now.